This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

Effect of Bacillus Subtilis DE111® on Daily Bowel Movements

Sponsored by Deerland Enzymes

About this trial

Last updated 6 years ago

Study ID

DE111Reg

Status

Completed

Type

Interventional

Phase

N/A

Placebo

No

Accepting

18-75 Years
18 to 65 Years
All
All

Trial Timing

Ended 8 years ago

What is this trial about?

The purpose of this study is to determine the efficacy of Bacillus subtilis DE111® probiotic for regulation of bowel movements.

What are the participation requirements?

Yes

Inclusion Criteria

- Participants suffering from occasional constipation and/or diarrhea will be eligible for participation.

No

Exclusion Criteria

- Blood CRP levels for each participant will be monitored at days 0, 60 and 105 of this study. Participants with CRP levels greater than 5mg/l on day 0 of the study will be excluded from further participation as this level is indicative of underlying inflammatory bowel disease. Participants excluded under such conditions will be instructed to seek further treatment with their health care provider.

Locations

Location

Status